Bank of America’s PAVmed Inc. Series Z Warrant PAVMZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-100
| Closed | – | – | 8760 |
|
|
2025
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 8645 |
|
|
2024
Q4 | $1 | Hold |
100
| – | – | ﹤0.01% | 8153 |
|
|
2024
Q3 | $2 | Hold |
100
| – | – | ﹤0.01% | 8122 |
|
|
2024
Q2 | $2 | Hold |
100
| – | – | ﹤0.01% | 8160 |
|
|
2024
Q1 | $4 | Hold |
100
| – | – | ﹤0.01% | 7601 |
|
|
2023
Q4 | $11 | Hold |
100
| – | – | ﹤0.01% | 7766 |
|
|
2023
Q3 | $12 | Hold |
100
| – | – | ﹤0.01% | 7615 |
|
|
2023
Q2 | $16 | Hold |
100
| – | – | ﹤0.01% | 7530 |
|
|
2023
Q1 | $15 | Buy |
+100
| New | +$20 | ﹤0.01% | 7590 |
|
|
2022
Q4 | – | Sell |
-1,000
| Closed | – | – | 8480 |
|
|
2022
Q3 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 8268 |
|
|
2022
Q2 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 8475 |
|
|
2022
Q1 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 8149 |
|
|
2021
Q4 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 8015 |
|
|
2021
Q3 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 7668 |
|
|
2021
Q2 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 7435 |
|
|
2021
Q1 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 7206 |
|
|
2020
Q4 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 7026 |
|
|
2020
Q3 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 6800 |
|
|
2020
Q2 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 6762 |
|
|
2020
Q1 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 6745 |
|
|
2019
Q4 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 7477 |
|
|
2019
Q3 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 7564 |
|
|
2019
Q2 | $0 | Buy |
+1,000
| New | +$400 | ﹤0.01% | 7457 |
|
Bank of America's PAVMZ Position: Q2 2025 in Review
Bank of America sold out of PAVmed Inc. Series Z Warrant (PAVMZ) in Q2 2025, closing a stake of 100 shares.
Bank of America first reported a position in PAVMZ in Q2 2019 and held it in 23 quarters. The position peaked at $7K in Q3 2021. 0 funds tracked by Wall St. Rank hold PAVMZ as of Q2 2025.
- Bank of America reported no remaining PAVmed Inc. Series Z Warrant position as of Q2 2025 after selling out during the quarter.
- Bank of America sold 100 PAVmed Inc. Series Z Warrant shares in Q2 2025.
- Bank of America first reported a position in PAVmed Inc. Series Z Warrant in Q2 2019 and held it in 23 quarters.
- Bank of America's PAVmed Inc. Series Z Warrant position peaked at $7K in Q3 2021.
- 0 funds tracked by Wall St. Rank held PAVmed Inc. Series Z Warrant as of Q2 2025.
Based on Bank of America's 13F filing for Q2 2025, filed 14 Aug 2025.